Meserve, J., Aniwan, S., Koliani-Pace, J. L., Shashi, P., Weiss, A., Faleck, D., Winters, A., Chablaney, S., Kochhar, G., Boland, B., Singh, S., Hirten, R., Shmidt, E., Bohm, M., Sagi, S. V., Fischer, M., Lukin, D., Hudesman, D., Chang, S., Sultan, K., Swaminath, A., Gupta, N., Kane, S., Loftus, E. V., Shen, B., Sands, B. E., Colombel, J. -., Siegel, C. A., Sandborn, W. J., & Dulai, P. S. (n.d.). dOP006 A multicentre cohort study to assess the safety of vedolizumab for inflammatory bowel disease. Journal of Crohn's and colitis, 12, S034. http://access.bl.uk/ark:/81055/vdc_100095512627.0x000010